Feasibility Evidence
The study used a single-arm, non-randomised, prospective mixed-methods feasibility design. The evaluation was guided by the RE-AIM framework. The study supports feasibility claims but not efficacy claims because it lacked randomisation, a…
1 sources - 4 claims
The study used a single-arm, non-randomised, prospective mixed-methods feasibility design. The evaluation was guided by the RE-AIM framework. The study supports feasibility claims but not efficacy claims because it lacked randomisation, a control group and long follow-up. The study supports a tiered implementation strategy tailored to palliative medicine, oncology and outpatient cardiology.